{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T22:11:08Z","timestamp":1783980668220,"version":"3.55.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006190","name":"Veterans Affairs Office of Research & Development","doi-asserted-by":"publisher","award":["MHBC-007-19F"],"award-info":[{"award-number":["MHBC-007-19F"]}],"id":[{"id":"10.13039\/100006190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jpsychires.2023.03.037","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T14:40:53Z","timestamp":1680187253000},"page":"393-401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["The efficacy and safety of buprenorphine for the treatment of depression: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"161","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5967-0883","authenticated-orcid":false,"given":"Natalie B.","family":"Riblet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinong","family":"Young-Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Shiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula P.","family":"Schnurr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley V.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpsychires.2023.03.037_bib1","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1186\/s13063-018-2843-9","article-title":"The effectiveness of different singly administered high doses of buprenorphine in reducing suicidal ideation in acutely depressed people with co-morbid opiate dependence: a randomized, double-blind, clinical trial","volume":"19","author":"Ahmadi","year":"2018","journal-title":"Trials"},{"issue":"1\u20132","key":"10.1016\/j.jpsychires.2023.03.037_bib2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0376-8716(99)00074-5","article-title":"Efficacy of daily and alternate-day dosing regimens with the combination buprenorphine-naloxone tablet","volume":"58","author":"Amass","year":"2000","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.jpsychires.2023.03.037_bib3","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s40273-021-01021-w","article-title":"The increasing economic burden with additional steps of pharmacotherapy in major depressive disorder","volume":"39","author":"Arnaud","year":"2021","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jpsychires.2023.03.037_bib4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1370\/afm.1260","article-title":"Severity of depression and magnitude of productivity loss","volume":"9","author":"Beck","year":"2011","journal-title":"Ann. Fam. Med."},{"issue":"1","key":"10.1016\/j.jpsychires.2023.03.037_bib5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/HRP.0000000000000242","article-title":"Novel targets to treat depression: opioid-based therapeutics","volume":"28","author":"Browne","year":"2020","journal-title":"Harv. Rev. Psychiatr."},{"issue":"4","key":"10.1016\/j.jpsychires.2023.03.037_bib6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1176\/appi.ajp.2013.13030325","article-title":"Comprehensive meta-analysis of excess mortality in depression in the general community versus patients with specific illnesses","volume":"171","author":"Cuijpers","year":"2014","journal-title":"Am. J. Psychiatr."},{"issue":"11","key":"10.1016\/j.jpsychires.2023.03.037_bib7","first-page":"925","article-title":"Treatment outcomes for depression: challenges and opportunities","volume":"7","author":"Cuijpers","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2023.03.037_bib8","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","article-title":"Chapter 10: analysing data and undertaking meta-analyses","author":"Deeks","year":"2021"},{"key":"10.1016\/j.jpsychires.2023.03.037_bib9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jad.2020.03.089","article-title":"A meta-analysis of the potential antidepressant effects of buprenorphine versus placebo as an adjunctive pharmacotherapy for treatment-resistant depression","volume":"271","author":"Dinoff","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.jpsychires.2023.03.037_bib10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00213-010-1898-4","article-title":"Acute effects of intramuscular and sublingual buprenorphine and buprenorphine\/naloxone in non-dependent opioid abusers","volume":"211","author":"Duke","year":"2010","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.jpsychires.2023.03.037_bib11","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1038\/npp.2014.330","article-title":"Evaluation of opioid modulation in major depressive disorder","volume":"40","author":"Ehrich","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2023.03.037_bib12","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1749-6632.1982.tb39483.x","article-title":"Possible antidepressive effects of opioids: action of buprenorphine","volume":"398","author":"Emrich","year":"1982","journal-title":"Ann. NY. Acad. Sci."},{"issue":"8300","key":"10.1016\/j.jpsychires.2023.03.037_bib13","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(82)90727-9","article-title":"Antidepressant effects of buprenorphine","volume":"2","author":"Emrich","year":"1982","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jpsychires.2023.03.037_bib14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1176\/appi.ajp.2015.15070921","article-title":"Opioid modulation with Buprenorphine\/Samidorphan as adjunctive treatment for inadequate response to antidepressants: a randomized double-blind placebo-controlled trial","volume":"173","author":"Fava","year":"2016","journal-title":"Am. J. Psychiatr."},{"issue":"7","key":"10.1016\/j.jpsychires.2023.03.037_bib15","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/s41380-018-0284-1","article-title":"Opioid system modulation with buprenorphine\/samidorphan combination for major depressive disorder: two randomized controlled studies","volume":"25","author":"Fava","year":"2020","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2023.03.037_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0033291721001549","article-title":"Suicide rates among people with serious mental illness: a systematic review and meta-analysis","author":"Fu","year":"2021","journal-title":"Psychol. Med."},{"issue":"2","key":"10.1016\/j.jpsychires.2023.03.037_bib17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","article-title":"Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"9","year":"2022","journal-title":"Lancet Psychiatr."},{"key":"10.1016\/j.jpsychires.2023.03.037_bib18","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/archpsyc.1980.01780190040005","article-title":"Beta-endorphin: intravenous infusion causes behavioral change in psychiatric inpatients","volume":"37","author":"Gerner","year":"1980","journal-title":"Arch. Gen. Psychiatr."},{"issue":"1","key":"10.1016\/j.jpsychires.2023.03.037_bib19","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/acps.13477","article-title":"A comparison of mortality rates for buprenorphine versus methadone treatments for opioid use disorder","volume":"147","author":"Gottlieb","year":"2023","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jpsychires.2023.03.037_bib20","series-title":"GRADEpro Guideline Development Tool [Software]","year":"2021"},{"issue":"2","key":"10.1016\/j.jpsychires.2023.03.037_bib21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3102\/10769986006002107","article-title":"Distribution theory for Glass's estimator of effect size and related estimators","volume":"62","author":"Hedges","year":"1981","journal-title":"J. Educ. Stat."},{"key":"10.1016\/j.jpsychires.2023.03.037_bib22","series-title":"Statistical Methods for Meta-Analysis","author":"Hedges","year":"1985"},{"key":"10.1016\/j.jpsychires.2023.03.037_bib23","series-title":"Cochrane Handbook for Systematic Reviews of Interventions [e-Book]","year":"2021"},{"key":"10.1016\/j.jpsychires.2023.03.037_bib24","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","article-title":"Chapter 6: choosing effect measures and computing estimates of effect","author":"Higgins","year":"2022"},{"key":"10.1016\/j.jpsychires.2023.03.037_bib25","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev-pharmtox-010919-023317","article-title":"Kappa opioid receptor antagonists as potential therapeutics for stress-related disorders","volume":"60","author":"Jacobson","year":"2020","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jpsychires.2023.03.037_bib26","author":"Karp"},{"key":"10.1016\/j.jpsychires.2023.03.037_bib27","author":"Karp"},{"issue":"8","key":"10.1016\/j.jpsychires.2023.03.037_bib28","doi-asserted-by":"crossref","first-page":"e785","DOI":"10.4088\/JCP.13m08725","article-title":"Safety, tolerability, and clinical effect of low-dose buprenorphine for treatment-resistant depression in midlife and older adults","volume":"75","author":"Karp","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2023.03.037_bib29","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1017\/S2045796019000180","article-title":"The excess costs of depression: a systematic review and meta-analysis","volume":"29","author":"K\u00f6nig","year":"2020","journal-title":"Epidemiol. Psychiatr. Sci."},{"key":"10.1016\/j.jpsychires.2023.03.037_bib30","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3389\/fpsyg.2013.00863","article-title":"Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs","volume":"4","author":"Lakens","year":"2013","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jpsychires.2023.03.037_bib31","author":"Lenze"},{"issue":"5","key":"10.1016\/j.jpsychires.2023.03.037_bib32","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/ADM.0000000000000045","article-title":"A review of buprenorphine diversion and misuse: the current evidence base and experiences from around the world","volume":"8","author":"Lofwall","year":"2014","journal-title":"J. Addiction Med."},{"issue":"4","key":"10.1016\/j.jpsychires.2023.03.037_bib33","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/jnr.24269","article-title":"The opioid system and the social brain: implications for depression and suicide","volume":"98","author":"Lutz","year":"2020","journal-title":"J. Neurosci. Res."},{"issue":"7","key":"10.1016\/j.jpsychires.2023.03.037_bib34","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1176\/appi.ajp.2020.20060864","article-title":"Improving suicide prevention through evidence-based strategies: a systematic review","volume":"178","author":"Mann","year":"2021","journal-title":"Am. J. Psychiatr."},{"issue":"10254","key":"10.1016\/j.jpsychires.2023.03.037_bib35","first-page":"1","article-title":"Buprenorphine as a treatment for major depression and opioid use disorder. Review","volume":"2","author":"Namchuk","year":"2022","journal-title":"Adv. Drug. Alcohol. Res."},{"key":"10.1016\/j.jpsychires.2023.03.037_bib36","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1515\/ijamh-2013-0069","article-title":"Buprenorphine in the treatment of non-suicidal self-injury: a case series and discussion of the literature","volume":"25","author":"Norelli","year":"2013","journal-title":"Int. J. Adolesc. Med. Health"},{"key":"10.1016\/j.jpsychires.2023.03.037_bib37","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","article-title":"Chapter 13: assessing risk of bias due to missing results in a synthesis","author":"Page","year":"2021"},{"key":"10.1016\/j.jpsychires.2023.03.037_bib38","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jpsychires.2023.03.037_bib39","author":"Pathak"},{"issue":"2","key":"10.1016\/j.jpsychires.2023.03.037_bib40","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/jcph.1280","article-title":"Abuse potential of Buprenorphine\/Samidorphan combination compared to Buprenorphine and placebo: a phase 1 randomized controlled trial","volume":"59","author":"Pathak","year":"2019","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jpsychires.2023.03.037_bib42","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.2147\/DDDT.S72543","article-title":"Advances in the delivery of buprenorphine for opioid dependence","volume":"11","author":"Rosenthal","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"issue":"1","key":"10.1016\/j.jpsychires.2023.03.037_bib43","first-page":"9","article-title":"Opioidergic agents as antidepressants: rationale and promise. CNS","volume":"33","author":"Saxena","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.jpsychires.2023.03.037_bib44","series-title":"GRADE Handbook for Grading Quality of Evidence and Strength of Recommendations","year":"2013"},{"issue":"8","key":"10.1016\/j.jpsychires.2023.03.037_bib45","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.3390\/ijms19082410","article-title":"The efficacy of buprenorphine in major depression, treatment-resistant depression and suicidal behavior: a systematic review","volume":"19","author":"Serafini","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jpsychires.2023.03.037_bib46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/acps.13510","article-title":"Can buprenorphine reduce suicide mortality?","volume":"147","author":"Sher","year":"2023","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jpsychires.2023.03.037_bib47","first-page":"1","year":"2021"},{"key":"10.1016\/j.jpsychires.2023.03.037_bib48","series-title":"Stata: Release 17","year":"2021"},{"key":"10.1016\/j.jpsychires.2023.03.037_bib49","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jpsychires.2023.03.037_bib50","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jpsychires.2023.03.037_bib51","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s002130050066","article-title":"Effects of buprenorphine versus buprenorphine\/naloxone tablets in non-dependent opioid abusers","volume":"148","author":"Strain","year":"2000","journal-title":"Psychopharmacology"},{"issue":"13","key":"10.1016\/j.jpsychires.2023.03.037_bib52","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1038\/s41386-019-0451-3","article-title":"Results from a long-term open-label extension study of adjunctive buprenorphine\/samidorphan combination in patients with major depressive disorder","volume":"44","author":"Thase","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2023.03.037_bib53","series-title":"StatPearls","article-title":"Opioid antagonists","author":"Theriot","year":"2022"},{"key":"10.1016\/j.jpsychires.2023.03.037_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2020.111383","article-title":"The complex interplay between depression and multimorbidity in late life: risks and pathways","volume":"192","author":"Triolo","year":"2020","journal-title":"Mech. Ageing Dev."},{"issue":"3","key":"10.1016\/j.jpsychires.2023.03.037_bib55","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3102\/10769986030003261","article-title":"Bias and efficiency of meta-analytic variance estimators in the random-effects mode","volume":"30","author":"Viechtbauer","year":"2005","journal-title":"J. Educ. Behav. Stat."},{"key":"10.1016\/j.jpsychires.2023.03.037_bib56","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2147\/NDT.S198774","article-title":"Management of treatment-resistant depression: challenges and strategie","volume":"16","author":"Voineskos","year":"2020","journal-title":"Neuropsychiatric Dis. Treat."},{"issue":"4","key":"10.1016\/j.jpsychires.2023.03.037_bib57","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1176\/appi.ajp.2021.21070700","article-title":"Association of medication treatment for opioid use disorder with suicide mortality","volume":"179","author":"Watts","year":"2022","journal-title":"Am. J. Psychiatr."},{"issue":"5","key":"10.1016\/j.jpsychires.2023.03.037_bib58","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1176\/appi.ajp.2015.15040535","article-title":"Ultra-low-dose buprenorphine as a time-limited treatment for severe suicidal ideation: a randomized controlled trial","volume":"173","author":"Yovell","year":"2016","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2023.03.037_bib59","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2147\/NDT.S199245","article-title":"Buprenorphine\/samidorphan combination for the adjunctive treatment of major depressive disorder: results of a phase III clinical trial (FORWARD-3)","volume":"15","author":"Zajecka","year":"2019","journal-title":"Neuropsychiatric Dis. Treat."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395623001565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395623001565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:38:28Z","timestamp":1758368308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395623001565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":58,"alternative-id":["S0022395623001565"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2023.03.037","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy and safety of buprenorphine for the treatment of depression: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2023.03.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}